Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co‐Design Approach With General Practitioners and Patients
Basic & Clinical Pharmacology & Toxicology · 2025
DOI: 10.1111/bcpt.70091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2025. Verfasst von Kristie Rebecca Weir und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Deprescriptions, Inappropriate Prescribing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, Swiss Government Excellence Scholarship, Swiss National Science Foundation Scientific Exchanges grant.
Abstract (Originalsprache)
Proton Pump Inhibitors (PPIs) are widely prescribed medications globally. PPIs are often inappropriately used – for example, prescribed without a clear indication, at higher‐than‐necessary doses, or for longer durations than needed – resulting in increased risks of adverse health outcomes such as nutrient deficiencies, osteoporosis‐related fractures, and kidney disease. The effectiveness of current deprescribing interventions is inconsistent; this may relate to the misalignment with behavioural mechanisms, supporting the need for a mechanism‐driven approach that targets key behavioural determinants. We co‐designed a PPI deprescribing intervention with patients and health professionals for the Swiss primary care setting. This involved identifying behavioural determinants of PPI deprescribing from the literature at both the general practitioner (GP) and patient levels, mapping them to behaviour change techniques, selecting intervention elements, and developing contextualised intervention tools to effectively influence these determinants. The intervention tools were iteratively developed and assessed through qualitative methods with 16 patients and 18 health professionals. Participants considered the tools to be acceptable and practical for use in the Swiss primary care context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
- Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
- Institute of Psychology, University of Bern, Bern, Switzerland.
- Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
- Center for Healthcare Delivery Sciences (C4HDS) and Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Health Economics Facility, Department of Public Health, University of Basel, Basel, Switzerland.
ORCID-Profile: Kristie Rebecca Weir
Förderung
- Swiss National Science Foundation
- Swiss Government Excellence Scholarship
- Swiss National Science Foundation Scientific Exchanges grant
- Emerging Leader Investigator Grant Fellowship from the Australian National Health and Medical Research Council
- Postdoc Mobility Fellowship from the Swiss National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Zitieren
APA
Weir, K. R., Tombez, C., Mattmann, Y., Zambrano, S. C., Ferguson, E., Jungo, K. T., Zangger, M., Volken, S., Vallejo-Yagüe, E., Lüthold, R. V., Schulthess-Lisibach, A. E., Bieri, C., Barbier, M., Juillerat, P., Streit, S., & Inauen, J. (2025). Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co‐Design Approach With General Practitioners and Patients. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70091
Vancouver
Weir KR, Tombez C, Mattmann Y, Zambrano SC, Ferguson E, Jungo KT, et al. Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co‐Design Approach With General Practitioners and Patients. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.70091
BibTeX
@article{Weir2025,
author = {Weir, Kristie Rebecca and Tombez, Clémentine and Mattmann, Yvonne and Zambrano, Sofia C and Ferguson, Eliza and Jungo, Katharina Tabea and Zangger, Martina and Volken, Shana and Vallejo-Yagüe, Enriqueta and Lüthold, Renata Vidonscky and Schulthess-Lisibach, Angela Edith and Bieri, Christof and Barbier, Michaela and Juillerat, Pascal and Streit, Sven and Inauen, Jennifer},
title = {Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co‐Design Approach With General Practitioners and Patients},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2025},
doi = {10.1111/bcpt.70091}
}
EUVIMED